Copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jun 26, 2021; 9(18): 4668-4680
Published online Jun 26, 2021. doi: 10.12998/wjcc.v9.i18.4668
Published online Jun 26, 2021. doi: 10.12998/wjcc.v9.i18.4668
AWGS2019 vs EWGSOP2 for diagnosing sarcopenia to predict long-term prognosis in Chinese patients with gastric cancer after radical gastrectomy
Wen-Yi Wu, Zhe-Jing Chen, Xiao-Lei Chen, Qian-Tong Dong, Yong-Yu Bai, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China
Jiao-Jiao Dong, Department of Anesthesiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China
Xin-Ce Huang, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China
Author contributions: Bai YY and Dong QT designed the study; Huang XC, Wu WY, Dong JJ, and Chen ZJ collected the data; Chen ZJ and Chen XL analyzed and interpreted the data; Bai YY and Huang XC wrote the article; Dong JJ and Dong QT revised the article and took the decision to submit the article for publication.
Supported by Zhejiang Provincial Health Department Medical Support Discipline-Nutrition , No. 11-ZC24 ; and Wenzhou Municipal Science and Bureau , No. Y2020732 .
Institutional review board statement: This study was approved by the Ethical Review Board of the First Affiliated Hospital of Wenzhou Medical University (No. 2014063).
Informed consent statement: All study participants or their legal guardian provided informed written consent about personal and medical data collection prior to study enrolment.
Conflict-of-interest statement: The authors declare no conflict of interests.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yong-Yu Bai, MD, Surgeon, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Wenzhou Medical University, No. 2 Fuxue Lane, Wenzhou 325000, Zhejiang Province, China. baiyongyu@qq.com
Received: February 6, 2021
Peer-review started: February 6, 2021
First decision: March 16, 2021
Revised: March 23, 2021
Accepted: April 20, 2021
Article in press: April 20, 2021
Published online: June 26, 2021
Processing time: 124 Days and 23.4 Hours
Peer-review started: February 6, 2021
First decision: March 16, 2021
Revised: March 23, 2021
Accepted: April 20, 2021
Article in press: April 20, 2021
Published online: June 26, 2021
Processing time: 124 Days and 23.4 Hours
Core Tip
Core Tip: Stomach cancer is an important contributor to the global burden of cancer, especially to Asian countries, while sarcopenia is a nutrition-related disease and has a profound effect on patients with gastric cancer. Early diagnosis of sarcopenia may contribute to improving the prognosis of these patients. Even though a significant difference between Asian people and European people, EWGSOP2 is more widely adopted than AWGS2019 in Asian countries. This study is the first to determine which method is more appropriate for Chinese patients and may guide Asian clinicians to make clinical decision based on our own criterion.